1 Division of Pulmonary and Critical Care Medicine and.
2 Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1616-1624. doi: 10.1164/rccm.201710-2108OC.
There are limited data on factors in young adulthood that predict future lung disease.
To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults.
We examined prospective data from 2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years.
Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with -2.71 ml/yr excess decline in FEV (P < 0.001) and -2.18 in FVC (P < 0.001) as well as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema.
Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.
关于预测未来肺部疾病的青年期相关因素的数据有限。
在一项针对青年人群的基于人群的研究中,确定呼吸症状、肺健康丧失与新发呼吸道疾病之间的关系。
我们研究了 CARDIA(年轻人冠状动脉风险发展)研究的 2749 名参与者的前瞻性数据,这些参与者在基线和 2 年后完成了呼吸症状问卷,并且在 30 年内重复进行了肺活量测定。
在评估从第 5 年到第 30 年 FEV 和 FVC 下降、新发阻塞性和限制性肺功能障碍以及胸部计算机断层扫描上可见肺气肿的模型中,基线和第 2 年时的咳嗽或咳痰、支气管炎发作、喘息、呼吸急促和胸部疾病是主要预测变量。在调整协变量(包括体重指数、哮喘和吸烟)后,报告任何症状与 FEV 每年额外下降 2.71ml(P<0.001)和 FVC 每年额外下降 2.18ml(P<0.001)以及新发(支气管扩张前)阻塞性(比值比[OR],1.63;95%置信区间[CI],1.24-2.14)和限制性(OR,1.40;95% CI,1.09-1.80)肺功能障碍的几率增加相关。与咳嗽相关的症状(OR,1.56;95% CI,1.13-2.16)与未来肺气肿的几率增加相关。
青年期持续的呼吸道症状与肺功能下降加速、新发阻塞性和限制性肺功能障碍以及未来影像学肺气肿的几率增加相关。